BNTX logo

BNTX
BioNTech SE - ADR

19,125
Mkt Cap
$22.44B
Volume
1.57M
52W High
$124.00
52W Low
$79.52
PE Ratio
-17.07
BNTX Fundamentals
Price
$89.27
Prev Close
$89.31
Open
$89.00
50D MA
$105.31
Beta
0.86
Avg. Volume
617,511.21
EPS (Annual)
-$5.30
P/B
0.99
Rev/Employee
$414,872.02
$5,894.82
Loading...
Loading...
News
all
press releases
Hudson Bay Capital Management LP Acquires 55,004 Shares of BioNTech SE Sponsored ADR $BNTX
Hudson Bay Capital Management LP boosted its stake in BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 36.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 205,004 shares of the company's stock after purchasin...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Groupama Asset Managment Trims Holdings in BioNTech SE Sponsored ADR $BNTX
Groupama Asset Managment reduced its holdings in shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 13.4% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 193,402 shares of the company's stock after selling 29,823 shares during the period...
MarketBeat·3d ago
News Placeholder
BioNTech (NASDAQ:BNTX) Earns "Buy" Rating from Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft restated a "buy" rating on shares of BioNTech in a research report on Tuesday...
MarketBeat·5d ago
News Placeholder
125,000 Shares in BioNTech SE Sponsored ADR $BNTX Purchased by Ghisallo Capital Management LLC
Ghisallo Capital Management LLC acquired a new stake in BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) in the third quarter, according to the company in its most recent 13F filing with the...
MarketBeat·8d ago
News Placeholder
Wall Street Zen Downgrades BioNTech (NASDAQ:BNTX) to Sell
Wall Street Zen lowered BioNTech from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·8d ago
News Placeholder
BioNTech (NASDAQ:BNTX) Given New $130.00 Price Target at Citigroup
Citigroup decreased their price objective on BioNTech from $145.00 to $130.00 and set a "buy" rating for the company in a report on Wednesday...
MarketBeat·11d ago
News Placeholder
BioNTech (NASDAQ:BNTX) Sees Large Volume Increase - Here's What Happened
BioNTech (NASDAQ:BNTX) Sees Large Volume Increase - Still a Buy...
MarketBeat·11d ago
News Placeholder
TD Cowen Has Lowered Expectations for BioNTech (NASDAQ:BNTX) Stock Price
TD Cowen reduced their target price on shares of BioNTech from $116.00 to $94.00 and set a "hold" rating for the company in a research note on Wednesday...
MarketBeat·11d ago
News Placeholder
BMO Capital Markets Issues Pessimistic Forecast for BioNTech (NASDAQ:BNTX) Stock Price
BMO Capital Markets cut their target price on shares of BioNTech from $143.00 to $128.00 and set an "outperform" rating on the stock in a research note on Wednesday...
MarketBeat·11d ago
News Placeholder
BioNTech (NASDAQ:BNTX) Receives "Buy" Rating from The Goldman Sachs Group
The Goldman Sachs Group reissued a "buy" rating on shares of BioNTech in a research note on Wednesday...
MarketBeat·11d ago
<
1
2
...
>

Latest BNTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.